首页> 外国专利> Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label

Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label

机译:与肿瘤抗原结合的第一非标记单克隆抗体和用NIR荧光标记物标记的非交叉反应性第二单克隆抗体的组成

摘要

This invention relates to a composition of a non-labeled monoclonal antibody binding to a tumor antigen and a second monoclonal antibody labeled with a NIR fluorescence label, binding to the same tumor antigen, wherein the first and second antibody exhibit no cross reactivity. The composition can be used for the treatment of patients suffering of solid tumors which are associated with an overexpression of such a tumor antigen. The invention further relates to a the co-administration of said first and second antibody as wells as to a method of acquiring a NIR fluorescence images of such tumors or the patients suffering from such tumors during the treatment of said patient with such composition.
机译:本发明涉及与肿瘤抗原结合的非标记单克隆抗体和与相同肿瘤抗原结合的,用NIR荧光标记物标记的第二单克隆抗体的组合物,其中第一和第二抗体没有交叉反应性。该组合物可用于治疗患有与这种肿瘤抗原的过表达有关的实体瘤的患者。本发明进一步涉及所述第一抗体和第二抗体的共同给药以及在用所述组合物治疗所述患者期间获取所述肿瘤或患有所述肿瘤的患者的NIR荧光图像的方法。

著录项

  • 公开/公告号US9687568B2

    专利类型

  • 公开/公告日2017-06-27

    原文格式PDF

  • 申请/专利权人 HOFFMANN-LA ROCHE INC.;

    申请/专利号US201313961167

  • 发明设计人 MAX HASMANN;HELMUT LENZ;WERNER SCHEUER;

    申请日2013-08-07

  • 分类号A61K49;A61K39/395;

  • 国家 US

  • 入库时间 2022-08-21 13:44:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号